On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine

Acta Tropica

Volumn 89, Issue 1, 2003, Pages 13-16

  Costa, G ^a   Aguiar, B G ^a   Coelho, P M Z ^b   Cunha Melo, J R ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa de Misericordia de Goiania   (Brazil)

Author keywords

Murine schistosomiasis mansoni; Oxamniquine; Portal pressure

Indexed keywords

OXAMNIQUINE;

SCHISTOSOMIASIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DRUG EFFECT; MALE; MOUSE; MULTICHANNEL RECORDER; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TREATMENT OUTCOME;

ANIMALIA; MURINAE; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 0242577444     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(03)00202-X     Document Type: Article

References (27)

1. Andrade Z.A. Pathogenesis of pipe-stem fibrosis of the liver (experimental observation of murine schistosomiasis). Mem. Inst. Oswaldo Cruz. 82:1987;325-334.
2. Andrade Z.A. Evolution and involution of hepatosplenic schistosomiasis. Mem. Inst. Oswaldo Cruz. 84:1989;58-75.
3. Andrade Z.A. Morphological features of collagen degradation in advanced hepatic schistosomiasis in man. Mem. Inst. Oswaldo Cruz. 87:1992;129-138.
4. Andrade Z.A., Brito P.A. Evolution of the schistosomal hepatic vascular lesions after specific chemotherapy. Am. J. Pathol. 30:1981;1223-1227.
5. Andrade Z.A., Cheever A.W. Alterations of the intrahepatic vasculature in hepatosplenic schistosomiasis mansoni. Am. J. Trop. Med. Hyg. 20:1971;425-432.
6. Andrade Z.A., Cheever A.W. Characterization of the murine model of schistosomal hepatic periportal fibrosis (pipe stem fibrosis). Int. J. Exp. Pathol. 74:1993;195-202.
7. Andrade Z.A., Grimaud J.A. Evolution of the schistosomal hepatic lesions in mice after curative chemotherapy. Am. J. Pathol. 124:1986;59-65.
8. Andrade Z.A., Grimaud J. Morphology of chronic collagen resorption study on a late stage of schistosomal involution. Am. J. Pathol. 132:1988;389-399.
9. Baki C.A., Guerret S., Grimaud J.A., Chevalier M. Liver fibrosis in unisexual murine Schistosomiasis: quantitative study and morphological changes in mice with chronic infection. Cell Mol. Biol. 44:1998;627-633.
10. Bina J.C., Prata A. Regressão da hepatoesplenomegalia pelo tratamento específico da esquistossomose. Rev. Soc. Med. Trop. 16:1993;213-218.
11. Cheever A.W. Pathogenesis of Schistosoma mansoni infection. Mem. Inst. Oswaldo Cruz. 87:1992;337-340.
12. Cheever A.W., Xu Y., Macedonia J.G., Cox T., Hieny S., Sher A. The role of cytokines in the pathogenesis of hepatic granulomatous disease in Schistosoma mansoni infected mice. Mem. Inst. Oswaldo Cruz. 87:1992;81-85.
13. De Witt W.B., Warren K.S. Hepatosplenic schistosomiasis in mice. Am. J. Trop. Med. Hyg. 8:1959;440-446.
14. Dietze R.S., Prata A. Rate of reversion of hepatosplenic schistosomiasis after specific therapy. Rev. Soc. Bras. Med. Trop. 19:1986;60-73.
15. Homeida, M.A., Fenwick, A., Defalla, A.A., Suliman, S., Kardeman, M.W., Eltom, I. et al., 1988. Effect of antischistosomal chemotherapy on prevalence of Symmers fibrosis in Sudanese villages. Lancet II, 437-439.
16. Jacobs W., Bogers J., Deelder A., Wery M., Van Marck E. Adult Schistosoma mansoni worms positively modulate soluble egg antigen-induced inflammatory hepatic granuloma formation in vivo. Stereological analysis and immunophenotyping of extracellular matrix proteins, adhesion molecules, and chemokines. Am. J. Pathol. 150:1997;2003-2045.
17. Kovacs E.J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissues. Immunol. Today. 12:1991;17-23.
18. McHugh S.M., Coulson P.S., Wilson R.A. Pathological induced alterations in the dimensions of the hepatic portal vasculature in mice infected with Schistosoma mansoni. Parasitology. 94:1987;69-80.
19. Mohamed-Ali Q., Boehring-Schwerdtfeger E., Abdel-Rahim I.M., Schlake J., Kardoff R., Franke D., et al. Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity 7 months after treatment with praziquantel. Am. J. Trop. Med. Hyg. 44:1991;444-451.
20. Pellegrino J., Siqueira A.F. Técnica de perfusão para colheita de Schistosoma mansoni em cobaias experimentalmente infectadas. Rev. Bras. Malariol. Doenças Tropicais. 8:1956;589-597.
21. + lymphocites within schistosomal egg granulomas as a source of an apparently novel fibroblast growth factor (FsF/1). J. Immunol. 148:1992;3583-3587.
22. Prakash S., Portlethwaite A.E., Stricllin G.P., Wyler D.J. Fibroblast stimulation in schistosomiasis. IX. Schistosomal egg granulomas from congenital athymic mice are deficient in production of fibrogenic factors. J. Immunol. 144:1992;317-322.
23. Silva C.L., Morel N.B., Lenzi H.L., Noel F. Increased reactivity to 5-hydroxytryptamine of portal veins from mice infected with Schistosoma mansoni. Comp. Biochem. Physiol. Part A. 120:1988;417-423.
24. Silva C.L., Lenzi H.L., Silva V.F., Paulo F.O., Noel F. Cellular mechanisms involved in the increased contraction of portal veins from Schistosoma mansoni-infected mice. Parasitol. Res. 89:2003;16-22.
25. Warren K.S., DeWitt W.B. Production of portal hypertension and esophageal varices in the mouse. Proc. Soc. Exp. Biol. Med. 98:1958;99-101.
26. WHO, 1993. The Control of Schistosomiasis. Second Report of WHO Expert Committee. WHO Technical Report Series No. 830.
27. Wyler D.J. Molecular and cellular basis of hepatic fibrogenesis in experimental schistosomiasis mansoni infection. Mem. Inst. Oswaldo Cruz. 87:1992;117-125.